N

Nyxoah SA
D

NYXH

8.44000
USD
0.24
(2.93%)
Market Closed
Volume
984
EPS
-2
Div Yield
-
P/E
-5
Market Cap
315,563,287
News

Title: Nyxoah SA

Sector: Healthcare
Industry: Medical Instruments & Supplies
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.